EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"I12 – Health Production"
Narrow search

Narrow search

Year of publication
Subject
All
Utility 2 Angina 1 C18 – Methodological Issues: General 1 Complementary and alternative medicine 1 Cost-effectiveness 1 Costs 1 Cost–Benefit Analysis 1 D61 - Allocative Efficiency 1 Economic evaluations 1 H51 - Government Expenditures and Health 1 Homeopathy 1 I10 – General 1 I11 – Analysis of Health Care Markets 1 I12 - Health Production 1 I12 – Health Production 1 I12: Health Production 1 I13 – Health Insurance 1 I15 – Health and Economic Development 1 I31: General Welfare 1 Maximal endurable time 1 Pectoris 1 Placebo 1 Preference reversal 1 Public and Private 1 QALY 1 Quality of Life 1 Ranolazine 1 Standard gamble 1 Trade-off 1
more ... less ...
Online availability
All
Undetermined 3
Type of publication
All
Article 3
Language
All
Undetermined 3
Author
All
Dymitr, Zofia 1 Hidalgo-Vega, Álvaro 1 Ramos-Goñi, Juan 1 Simoens, Steven 1 Stalmeier, P. 1 Verheijen, A. 1 Viksveen, Petter 1 Villoro, Renata 1
more ... less ...
Published in...
All
The European Journal of Health Economics 3
Source
All
RePEc 3
Showing 1 - 3 of 3
Cover Image
Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
Hidalgo-Vega, Álvaro; Ramos-Goñi, Juan; Villoro, Renata - In: The European Journal of Health Economics 15 (2014) 9, pp. 917-925
Ranolazine is a highly efficient add-on therapy for the symptomatic treatment of chronic angina pectoris in patients who are inadequately controlled by, or intolerant to, first-line antianginal therapies in Spain. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014
Persistent link: https://www.econbiz.de/10011151208
Saved in:
Cover Image
Economic evaluations of homeopathy: a review
Viksveen, Petter; Dymitr, Zofia; Simoens, Steven - In: The European Journal of Health Economics 15 (2014) 2, pp. 157-174
Although the identified evidence of the costs and potential benefits of homeopathy seemed promising, studies were highly heterogeneous and had several methodological weaknesses. It is therefore not possible to draw firm conclusions based on existing economic evaluations of homeopathy....
Persistent link: https://www.econbiz.de/10010993855
Saved in:
Cover Image
Maximal endurable time states and the standard gamble: more preference reversals
Stalmeier, P.; Verheijen, A. - In: The European Journal of Health Economics 14 (2013) 6, pp. 971-977
The observed reversal rate for the standard gamble is similar to rates observed previously with the TTO method. Utility measurement of poor health states is problematic, both with the TTO and standard gamble methods. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2013
Persistent link: https://www.econbiz.de/10010993966
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...